Literature DB >> 23166010

Phelan-McDermid syndrome: clinical report of a 70-year-old woman.

Willem M A Verhoeven1, Jos I M Egger, Ruthy Cohen-Snuijf, Sarina G Kant, Nicole de Leeuw.   

Abstract

Phelan-McDermid or 22q13.3 deletion syndrome is characterized by global intellectual disability, childhood hypotonia, severely delayed or absent speech, features of autism spectrum disorder, without any major dysmorphisms or somatic anomalies. It is typically diagnosed before adolescence and data about adult patients are virtually absent. The expression of its phenotypical characteristics appears to be linearly related to the deletion size. Here, an intellectually disabled geriatric female patient is described with a long history of challenging behaviors in whom Phelan-McDermid syndrome was demonstrated. Detailed analysis of the patient's history and functioning resulted in a psychiatric diagnosis of atypical bipolar disorder and her behavior significantly improved upon maintenance treatment with a mood stabilizing agent. The present article confirms recent findings that atypical bipolar disorder may be part of the psychopathological phenotype of Phelan-McDermid syndrome, reason why careful etiological search is warranted, also in the geriatric population.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23166010     DOI: 10.1002/ajmg.a.35597

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  14 in total

1.  Phelan-McDermid syndrome presenting with autistic spectrum: are we underdiagnosing chromosomal diseases in patients with autism?

Authors:  Wladimir Bocca Vieira de Rezende Pinto; José Luiz Pedroso; Paulo Victor Sgobbi de Souza; Acary Souza Bulle Oliveira; Orlando Graziani Povoas Barsottini
Journal:  J Neurol       Date:  2013-09-29       Impact factor: 4.849

Review 2.  Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome.

Authors:  Brianna Dyar; Erika Meaddough; Sara M Sarasua; Curtis Rogers; Katy Phelan; Luigi Boccuto
Journal:  Genes (Basel)       Date:  2021-07-30       Impact factor: 4.096

Review 3.  Modeling autism by SHANK gene mutations in mice.

Authors:  Yong-Hui Jiang; Michael D Ehlers
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

Review 4.  Framework for assessing individuals with rare genetic disorders associated with profound intellectual and multiple disabilities (PIMD): the example of Phelan McDermid Syndrome.

Authors:  Latha Soorya; Jill Leon; M Pilar Trelles; Audrey Thurm
Journal:  Clin Neuropsychol       Date:  2017-12-21       Impact factor: 3.535

5.  Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports.

Authors:  Sylvie Serret; Susanne Thümmler; Emmanuelle Dor; Stephanie Vesperini; Andreia Santos; Florence Askenazy
Journal:  BMC Psychiatry       Date:  2015-05-07       Impact factor: 3.630

Review 6.  Molecular handoffs in nitrergic neurotransmission.

Authors:  Arun Chaudhury
Journal:  Front Med (Lausanne)       Date:  2014-04-10

7.  Case report: an unexpected link between partial deletion of the SHANK3 gene and Heller's dementia infantilis, a rare subtype of autism spectrum disorder.

Authors:  Anne Philippe; Yann Craus; Marlène Rio; Nadia Bahi-Buisson; Nathalie Boddaert; Valérie Malan; Jean-Paul Bonnefont; Laurence Robel
Journal:  BMC Psychiatry       Date:  2015-10-21       Impact factor: 3.630

8.  Reduced Efficacy of d-Amphetamine and 3,4-Methylenedioxymethamphetamine in Inducing Hyperactivity in Mice Lacking the Postsynaptic Scaffolding Protein SHANK1.

Authors:  A Özge Sungur; Tobias M Redecker; Elena Andres; Wiebke Dürichen; Rainer K W Schwarting; Adriana Del Rey; Markus Wöhr
Journal:  Front Mol Neurosci       Date:  2018-11-16       Impact factor: 5.639

9.  Psychiatric illness and regression in individuals with Phelan-McDermid syndrome.

Authors:  Teresa M Kohlenberg; M Pilar Trelles; Brittany McLarney; Catalina Betancur; Audrey Thurm; Alexander Kolevzon
Journal:  J Neurodev Disord       Date:  2020-02-12       Impact factor: 4.025

Review 10.  A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts.

Authors:  Liliana Dell'Osso; Claudia Del Grande; Camilla Gesi; Claudia Carmassi; Laura Musetti
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-11       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.